Evaluation of T cells infiltration inhibition in brain by immunohistochemistry during experimental cerebral malaria
1Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, 160014 India.
Abstract:
Plasmodium berghei ANKA is known to be responsible for causing neurological complications in susceptible strain of mice. Despite the decades of research, pathogenesis of cerebral malaria is still unknown. Histopathological and immunofluorescent staining was performed on brain of P. berghei ANKA infected and artesunate-sulphadoxine-pyrimethamine (AS + SP) treated mice to understand the pathogenesis of experimental cerebral malaria in present study. Cerebral vessels were found to be congested with infected/non-infected RBCs and various leukocytes in infected mice. Immunofluorescent staining identified the localisation of CD3+, CD4+ and CD8+ T cells in brain of infected and treated mice. P. berghei infected mice exhibited higher expression of CD3+, CD4+ and CD8+ T cells in brain cortex as compared to mice treated with artesunate-sulphadoxine-pyrimethamine. No sign of injury was observed in brain of treated mice in histopathological analysis. All treated mice survived up to 1 month, whereas, all infected mice died by D15 post infection due to neuro-inflammation.
Insights
Experimental cerebral malaria in mice involves neuroinflammation and T cell infiltration in the brain. Artesunate-sulphadoxine-pyrimethamine treatment prevented mortality and brain injury in infected mice.
Area of Science:
- Neuroscience
- Immunology
- Parasitology
Background:
- Cerebral malaria, a severe complication of Plasmodium infection, has an unknown pathogenesis despite extensive research.
- Plasmodium berghei ANKA in mice serves as a model for studying cerebral malaria and its neurological effects.
Purpose of the Study:
- To investigate the pathogenesis of experimental cerebral malaria using histopathological and immunofluorescent staining.
- To evaluate the effects of artesunate-sulphadoxine-pyrimethamine (AS+SP) treatment on cerebral malaria progression and outcomes.
Main Methods:
- Histopathological analysis of brain tissue from infected and treated mice.
- Immunofluorescent staining to identify and localize T cells (CD3+, CD4+, CD8+) in the brain.
- Monitoring survival rates and clinical signs in infected and treated mouse models.
Main Results:
- Cerebral vessels in infected mice showed congestion with red blood cells and leukocytes.
- Increased expression of CD3+, CD4+, and CD8+ T cells was observed in the brain cortex of infected mice compared to treated mice.
- Artesunate-sulphadoxine-pyrimethamine treatment prevented mortality and histopathological signs of brain injury, with all treated mice surviving for one month.
Conclusions:
- Neuroinflammation and T cell infiltration are key features of experimental cerebral malaria pathogenesis.
- Artesunate-sulphadoxine-pyrimethamine is effective in treating experimental cerebral malaria, preventing mortality and brain damage.
- Understanding T cell localization is crucial for developing targeted therapies for cerebral malaria.
Related Concept Videos
Feedback Inhibition
Immunocytochemistry and Immunohistochemistry
These...
Enzyme Inhibition
Inhibition of Cdk Activity
Cerebral Hemispheres
Experimental Determination of Chemical Formula


